首页> 外文OA文献 >68Ga and 188Re Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat Studies
【2h】

68Ga and 188Re Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat Studies

机译:68Ga和188Re淀粉基微粒作为肝细胞癌的治疗手段:放射标记和体内大鼠的初步研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This work aims to develop, validate and optimize the radiolabeling of Starch-Based Microparticles (SBMP) by 188Re and 68Ga in the form of ready-to-use radiolabeling kits, the ultimate goal being to obtain a unique theranostic vector for the treatment of Hepatocellular Carcinoma. METHODS: Optimal labeling conditions and composition of freeze-dried kits were defined by monitoring the radiochemical purity while varying several parameters. In vitro stability studies were carried out, as well as an in vivo biodistribution as a preliminary approach with the intra-arterial injection of 68Ga radiolabeled SBMP into the hepatic artery of DENA-induced rats followed by PET/CT imaging.RESULTS: Kits were optimized for 188Re and 68Ga with high and stable radiochemical purity (>95% and >98% respectively). The in vivo preliminary study was successful with more than 95% of activity found in the liver and mostly in the tumorous part.CONCLUSION: SBMP are a promising theranostic agent for the Selective Internal Radiation Therapy of Hepatocellular carcinoma
机译:这项工作旨在以现成的放射性标记试剂盒的形式开发,验证和优化188Re和68Ga对基于淀粉的微粒(SBMP)的放射性标记,最终目的是获得用于治疗肝细胞的独特的治疗学载体癌。方法:通过监测放射化学纯度,同时改变几个参数,确定最佳的标记条件和冻干试剂盒的组成。进行体外稳定性研究以及体内生物分布作为初步方法,将68Ga放射性标记的SBMP动脉内注射到DENA诱导的大鼠的肝动脉中,然后进行PET / CT成像。结果:优化了试剂盒188Re和68Ga具有高且稳定的放射化学纯度(分别> 95%和> 98%)。体内初步研究取得了成功,肝中活性超过95%,大部分在肿瘤部位。结论:SBMP是用于肝细胞癌选择性内部放射治疗的有前途的治疗药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号